首页 › 宫颈癌 › 阿拉巴马州 › Birmingham
Birmingham AL 宫颈癌临床试验
8项针对 宫颈癌的研究正在 Birmingham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
DESTINY-PANTUMOUR04
招募中观察性研究
- Research Site, Birmingham
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
招募中3 期
- University of Alabama- Birmingham ( Site 5015), Birmingham
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- University of Alabama Birmingham, Birmingham
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
招募中欢迎健康志愿者
- University of Alabama at Birmingham Cancer Center, Birmingham
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
招募中1 期
- The University of Alabama at Birmingham, Birmingham
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
招募中
- Cahaba Medical Care - West End, Birmingham
- Cahaba Medical Care - Ensley, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Birmingham
其他城市的 宫颈癌试验
- Houston, TX34 项研究
- Nashville, TN19 项研究
- New York City, NY19 项研究
- Boston, MA18 项研究
- Los Angeles, CA16 项研究
- Arlington, VA16 项研究
- San Antonio, TX14 项研究
- St. Louis, MO13 项研究
- Dallas, TX13 项研究
- Orlando, FL12 项研究
- Chicago, IL12 项研究
- Atlanta, GA11 项研究
Birmingham的其他研究
- 癌症（所有类型）30 项研究
- 乳腺癌24 项研究
- 肥胖症23 项研究
- 卵巢癌23 项研究
- 非小细胞肺癌22 项研究
- 急性髓系白血病21 项研究
- 多发性骨髓瘤18 项研究
- 慢性阻塞性肺病17 项研究
- 心血管疾病17 项研究
- 超重16 项研究
- 子宫内膜癌16 项研究
- 2型糖尿病16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。